Robeco Institutional Asset Management
PFE icon

Robeco Institutional Asset Management’s Pfizer PFE Stock Holding History

Robeco Institutional Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$287M Buy
11,918,197
+779,763
+7% +$20.4M 0.35% 57
2026
Q1 		$313M Buy
11,138,434
+1,267,791
+13% +$33.8M 0.45% 45
2025
Q4 		$246M Sell
9,870,643
-1,527,922
-13% -$38.5M 0.35% 60
2025
Q3 		$290M Buy
11,398,565
+1,247,082
+12% +$30.8M 0.42% 48
2025
Q2 		$246M Buy
10,151,483
+2,720,184
+37% +$63.4M 0.4% 55
2025
Q1 		$188M Buy
7,431,299
+1,053,482
+17% +$27.6M 0.37% 61
2024
Q4 		$169M Buy
6,377,817
+1,879,504
+42% +$51M 0.32% 64
2024
Q3 		$130M Buy
4,498,313
+2,459,666
+121% +$71.8M 0.26% 89
2024
Q2 		$57M Sell
2,038,647
-656,996
-24% -$18.1M 0.12% 165
2024
Q1 		$74.8M Sell
2,695,643
-853,329
-24% -$23.7M 0.16% 134
2023
Q4 		$102M Sell
3,548,972
-782,249
-18% -$23.6M 0.25% 96
2023
Q3 		$144M Sell
4,331,221
-970,003
-18% -$34.3M 0.38% 64
2023
Q2 		$194M Sell
5,301,224
-814,454
-13% -$31.7M 0.51% 48
2023
Q1 		$250M Sell
6,115,678
-131,668
-2% -$5.69M 0.68% 27
2022
Q4 		$320M Sell
6,247,346
-1,004,577
-14% -$48.2M 0.92% 11
2022
Q3 		$317M Sell
7,251,923
-369,902
-5% -$18M 1.03% 13
2022
Q2 		$400M Sell
7,621,825
-656,930
-8% -$33.5M 1.24% 9
2022
Q1 		$429M Sell
8,278,755
-208,901
-2% -$10.8M 1.01% 12
2021
Q4 		$501M Sell
8,487,656
-1,592,114
-16% -$78.9M 1.07% 11
2021
Q3 		$434M Sell
10,079,770
-273,637
-3% -$12.1M 0.96% 12
2021
Q2 		$405M Buy
10,353,407
+1,457,554
+16% +$56.7M 0.9% 14
2021
Q1 		$322M Sell
8,895,853
-312,302
-3% -$11.1M 0.79% 21
2020
Q4 		$339M Sell
9,208,155
-1,099,778
-11% -$40.3M 0.89% 19
2020
Q3 		$359M Buy
10,307,933
+2,740,833
+36% +$96.1M 1.11% 11
2020
Q2 		$235M Sell
7,567,100
-47,519
-0.6% -$1.61M 0.8% 19
2020
Q1 		$236M Sell
7,614,619
-22,087
-0.3% -$753K 0.95% 16
2019
Q4 		$284M Buy
7,636,706
+665,031
+10% +$23.7M 0.91% 16
2019
Q3 		$238M Sell
6,971,675
-694,090
-9% -$25.2M 0.84% 16
2019
Q2 		$315M Sell
7,665,765
-88,416
-1% -$3.51M 1.11% 8
2019
Q1 		$312M Buy
7,754,181
+142,329
+2% +$5.7M 1.15% 8
2018
Q4 		$315M Sell
7,611,852
-86,979
-1% -$3.61M 1.41% 4
2018
Q3 		$322M Buy
7,698,831
+218,582
+3% +$8.41M 1.28% 5
2018
Q2 		$257M Buy
7,480,249
+79,174
+1% +$2.71M 1.17% 7
2018
Q1 		$249M Buy
7,401,075
+3,186,333
+76% +$110M 1.17% 5
2017
Q4 		$145M Buy
4,214,742
+765,020
+22% +$26.1M 0.75% 24
2017
Q3 		$117M Buy
3,449,722
+27,189
+0.8% +$874K 0.73% 29
2017
Q2 		$109M Sell
3,422,533
-53,521
-2% -$1.69M 0.7% 30
2017
Q1 		$113M Buy
3,476,054
+106,592
+3% +$3.36M 0.75% 26
2016
Q4 		$104M Buy
3,369,462
+176,201
+6% +$5.38M 0.81% 21
2016
Q3 		$103M Buy
3,193,261
+883,428
+38% +$29.5M 0.76% 21
2016
Q2 		$77.2M Buy
2,309,833
+177,173
+8% +$5.65M 0.59% 39
2016
Q1 		$60M Sell
2,132,660
-136,245
-6% -$3.89M 0.48% 63
2015
Q4 		$69.5M Sell
2,268,905
-2,901,857
-56% -$91.3M 0.59% 40
2015
Q3 		$154M Sell
5,170,762
-998,011
-16% -$32M 1.17% 10
2015
Q2 		$196M Sell
6,168,773
-595,686
-9% -$19.4M 1.49% 6
2015
Q1 		$223M Sell
6,764,459
-660,806
-9% -$21M 1.68% 4
2014
Q4 		$219M Sell
7,425,265
-407,330
-5% -$11.7M 1.57% 7
2014
Q3 		$220M Buy
7,832,595
+126,494
+2% +$3.55M 1.57% 10
2014
Q2 		$217M Sell
7,706,101
-1,055,911
-12% -$30.1M 1.55% 8
2014
Q1 		$267M Buy
8,762,012
+577,408
+7% +$17.2M 2.05% 3
2013
Q4 		$238M Buy
8,184,604
+327,407
+4% +$9.53M 1.98% 5
2013
Q3 		$214M Sell
7,857,197
-196,757
-2% -$5.35M 2.08% 4
2013
Q2 		$214M Buy
+8,053,954
New +$223M 2.17% 4

Other funds holding PFE

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Robeco Institutional Asset Management's PFE Position: Q2 2026 in Review

Robeco Institutional Asset Management increased its Pfizer (PFE) stake by 7% in Q2 2026, buying an estimated $20.4M and bringing the position to 11,918,197 shares worth $287M. The position accounts for 0.35% of the portfolio, ranked #57.

Robeco Institutional Asset Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $501M in Q4 2021. 719 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Robeco Institutional Asset Management held 11,918,197 shares of Pfizer worth $287M as of Q2 2026.
  • Robeco Institutional Asset Management bought 779,763 Pfizer shares in Q2 2026, an estimated $20.4M.
  • Pfizer made up 0.35% of Robeco Institutional Asset Management's portfolio in Q2 2026, its #57 holding.
  • Robeco Institutional Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Robeco Institutional Asset Management's Pfizer position peaked at $501M in Q4 2021.
  • 719 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Robeco Institutional Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.